149 related articles for article (PubMed ID: 1681028)
1. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
[TBL] [Abstract][Full Text] [Related]
2. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
[TBL] [Abstract][Full Text] [Related]
3. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
Lake-Bakaar G; Bhat K; Govindarajan S
J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of HBV, HDV and HIV infections among intravenous drug addicts in Greece.
Roumeliotou-Karayannis A; Tassopoulos N; Karpodini E; Trichopoulou E; Kotsianopoulou M; Papaevangelou G
Eur J Epidemiol; 1987 Jun; 3(2):143-6. PubMed ID: 3475213
[TBL] [Abstract][Full Text] [Related]
6. Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis.
Buti M; Esteban R; Español MT; Malagelada A; Jardi R; Rodriguez-Frias F; Roget M; Guardia J
J Infect Dis; 1991 Jun; 163(6):1351-3. PubMed ID: 1674749
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.
Nicolini LA; Taramasso L; Schiavetti I; Giannini EG; Beltrame A; Feasi M; Cassola G; Grasso A; Bartolacci V; Sticchi L; Picciotto A; Viscoli C;
Antivir Ther; 2015; 20(2):193-7. PubMed ID: 24963642
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of HBV, HDV and HCV hepatitis markers in HIV-positive patients.
Francisci D; Baldelli F; Papili R; Stagni G; Pauluzzi S
Eur J Epidemiol; 1995 Apr; 11(2):123-6. PubMed ID: 7672063
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis delta in HIV-infected individuals in Europe.
Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
[TBL] [Abstract][Full Text] [Related]
10. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
11. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis delta virus RNA detection in chronic HBsAg carriers with and without HIV infection.
Castillo I; Bartolomé J; Madejón A; Melero M; Porres JC; Carreño V
Digestion; 1991; 48(3):149-56. PubMed ID: 1916035
[TBL] [Abstract][Full Text] [Related]
13. HCV, HIV, HBV and HDV infections in intravenous drug addicts.
Coppola RC; Manconi PE; Piro R; Di Martino ML; Masia G
Eur J Epidemiol; 1994 Jun; 10(3):279-83. PubMed ID: 7859838
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
León P; López JA; Contreras G; Echevarría JM
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of blood-borne viral infections in Afghanistan.
Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM
Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiology of hepatitis B and D virus infection among intravenous drug addicts in Israel.
Dan M; Rock M; Lilos P; Shany SB
Int J Epidemiol; 1993 Feb; 22(1):140-3. PubMed ID: 8449634
[TBL] [Abstract][Full Text] [Related]
17. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan.
Hsieh MH; Wang SC; Hsieh MY; Huang CF; Yeh ML; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2016 Oct; 32(10):526-530. PubMed ID: 27742037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
